Catheter Precision Received Chinese Patent For LockeT
Portfolio Pulse from Benzinga Newsdesk
Catheter Precision has received a Chinese patent for its LockeT device, which is used in cardiac procedures. This development could enhance the company's market position and product offerings.
September 24, 2024 | 12:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Catheter Precision, associated with VTAK, has received a Chinese patent for its LockeT device, which could strengthen its market position in cardiac procedures.
The Chinese patent for LockeT could enhance Catheter Precision's competitive edge and market reach in the medical device sector, positively impacting VTAK's stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80